Position in NVO
as of Jun 30, 2026
· filed Aug 18, 2026
Position Value
$9,588
+$2,238 QoQ
Shares Held
200
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,238
of 1,348 holders
Holding Since
Mar 2024
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Orion Capital Management LLC holds $6,945,115 across 9 Drug Manufacturers - General names. NVO ranks #8 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
8,139 | $2,048,097 | |
| 2 | LLY |
ELI LILLY & Co
|
1,396 | $1,674,404 | |
| 3 | JNJ |
Johnson & Johnson
|
5,098 | $1,294,739 | |
| 4 | MRK |
Merck & Co., Inc.
|
7,922 | $1,017,977 | |
| 5 | AMGN |
Amgen Inc
|
2,053 | $743,432 | |
| 6 | NVS |
Novartis AG
|
500 | $78,360 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
1,300 | $74,906 | |
| 8 | NVO |
Novo Nordisk A S
This page
|
200 | $9,588 |
All Filings in NVO
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,588 | 200 | Shares | Sole | 2026-08-18 | |
| 2026-03-31 | $7,350 | 200 | Shares | Sole | 2026-05-14 | |
| 2024-06-30 | $14,274 | 100 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $25,680 | 200 | Shares | Sole | 2024-05-10 | |
| No filing history on record for this holder in this stock. | ||||||